Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05765929
Other study ID # 47891
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 28, 2023
Est. completion date December 31, 2032

Study information

Verified date November 2022
Source Ostfold Hospital Trust
Contact Marius Molund, PhD
Phone 0047 90093988
Email mariusmolund@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the outcomes after non-operative treatment of weightbearing stable bi-and trimalleolar ankle fractures.


Recruitment information / eligibility

Status Recruiting
Enrollment 29
Est. completion date December 31, 2032
Est. primary completion date December 31, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - -With bi- and trimalleolar ankle fractures with less than 7 mm medial clear space on non-weightbearing radiographs that are deemed stable by weightbearing radiographs. - With type B medial malleolus fractures between the tip and the plafond and type C medial malleolus fractures at the level of the plafond (Herscovici classification). (6) - With fractures in the distal 1/3 of fibula (not-Maisonneuve) - Enabling stability evaluation within 14 days after injury - 18-75 years of age - with pre-injury walking ability without aids Exclusion Criteria: - - With primary unstable ankle fractures, > 7mm medial clear space on primary radiographs - With fracture reduction prior to initial radiographic evaluation, open fracture, fractures resulting from high-energy trauma or multi trauma and pathological fracture - With type A medial malleolus avulsion fractures < 5mm (at the tip of the malleolus), that are not suitable for surgical intervention. - With Herscovici type D fractures, involving Lauge-Hansen SA2 fractures (supracollicular fracture - vertical, oblique or transverse direction of the plafond) - With displaced posterior malleolus fractures that needs fixation in the judgement of the attending surgeon - With neuropathies and symptomatic joint diseases such as Rheumatoid Arthritis - That are assumed not compliant (such as drug abuse, cognitive- and/or psychiatric disorders) - With previous history ipsilateral ankle fracture - With previous history ipsilateral major ankle-/foot surgery - Who live outside the hospital catchment areas not available to follow up - With insufficient Norwegian or English language skills - Non-compliant

Study Design


Intervention

Other:
Non-operative treatment
Patients will be treated with a walker-orthosis for 6 weeks. Weightbearing as tolerated

Locations

Country Name City State
Norway Østfold Hospital Trust Sarpsborg Østfold

Sponsors (1)

Lead Sponsor Collaborator
Ostfold Hospital Trust

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Olerud Molander Score (OMAS) to measure a change over time Condition specific, patient reported measure of ankle-fracture symptoms 6 week, 12 weeks, 1year, 2 years
Secondary Manchester-Oxford Foot Questionnaire (MOxFQ) Patients reported outcomes 6 week, 12 weeks, 1year, 2 years
Secondary Range of Motion measured by a goniometer (ad modum Lindsjo) dorsiflexion and plantarflexion 6 week, 12 weeks, 1year, 2 years
Secondary Numeric Rating Scale (NRS) Ankle pain in rest, at night and in daily activities, a 11-point numeric scale ranging from 0-10 6 week, 12 weeks, 1year, 2 years
Secondary Euroqol questionnaire (EQ- 5D) Health related quality of life 6 week, 12 weeks, 1year, 2 years
Secondary Registrations of complications/adverse events Registration of loss of congruence, delayed union, non-union, thromboembolic events 0-2 years
Secondary Posttraumatic osteoarthritis (OA) CT-scan (Kellgren-Lawrence classification) 2 years and 5 years
See also
  Status Clinical Trial Phase
Completed NCT04437355 - Operative Treatment of Ankle Fractures N/A
Recruiting NCT05445960 - Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery N/A